Oxford Covid vaccine prompting immune response: AstraZeneca

Oxford's Covid-19 vaccine candidate prompts an immune response in both young and old adults, AstraZeneca Plc said. The Anglo-Swedish drugmaker is collaborating with the University of Oxford for the manufacturing of its ChAdOx1 vaccine for coronavirus.

Earlier on October 22, clinical trials for the University of Oxford's Covid-19 vaccine 'Covishield' resumed globally following a "voluntary pause". Clinical trials for the vaccine candidate are now underway in the US, UK, Brazil, South Africa and Japan.